FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2327243444> ?p ?o ?g. }

• W2327243444 endingPage "A48" @default.
• W2327243444 startingPage "A48.1" @default.
• W2327243444 abstract "<h3>Objective</h3> To assess the efficiency and safety of the use of different dual antiplatelet therapy in patients undergoing percutaneous coronary intervention. <h3>Methods</h3> Cochrane Library, MEDLINE, EMBASE, CBM, CNKI, and VIP, were searched up to October 2011. Randomized controlled trials comparing the efficiency and safety with short duration of treatment (≤6months) versus long duration of treatment ( > 6months) of dual antiplatelet therapy on percutaneous coronary intervention which have been reported were enrolled. No language restriction was enforced. The quality of the included studies was critically evaluated. Data analyses were performed using the Cochrane Collaboration’s RevMan 5.1 software. <h3>Results</h3> Eight trials were included. Three randomised controlled trials and five observational study trials met the inclusion criteria and were incorporated into the primary analysis. Meta-analysis showed that the incidence of death or myocardial infarction in long duration treatment group was lower than short duration treatment group in randomised controlled trials [<i>OR</i> = 0.74, 95% confidence interval [CI] 0.56 to 0.98, <i>P</i> < 0.0001]. Meanwhile, Combined observational studies showed that incidence of death or myocardial infarction in long duration treatment group was lower than short treatment group [<i>OR</i> = 0. 7, 95% confidence interval [CI]0. 45 to 1. 08, <i>P</i> = 0. 11]. We also explored the heterogeneity between the randomised controlled studies and observational studies. In randomised controlled trials, the incidence of major bleeding events of short treatment group was lower than long treatment group [<i>OR</i> = 1.29, 95% confidence interval [CI] 0.99 to 1.69, <i>P</i> = 0.06]. Meta-analysis of observational studies showed that the incidence of late stent thrombosis in long treatment group was lower than short treatment group [<i>OR</i> = 0.40, 95% confidence interval [CI] 0.15 to 1.07, <i>P</i> = 0.07]. <h3>Conclusions</h3> The long duration of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention can reduce the incidence of death or myocardial infarction. There is a trend of decreasing the rate of late stent thrombosis in long treatment group. The incidence of bleeding does not increase obviously in the long treatment group." @default.
• W2327243444 created "2016-06-24" @default.
• W2327243444 creator A5049712147 @default.
• W2327243444 creator A5059392164 @default.
• W2327243444 creator A5059439989 @default.
• W2327243444 creator A5079087568 @default.
• W2327243444 date "2013-04-01" @default.
• W2327243444 modified "2023-09-23" @default.
• W2327243444 title "ASSA13-10-19 The Optimal Duration of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis" @default.
• W2327243444 doi "https://doi.org/10.1136/heartjnl-2013-303992.144" @default.
• W2327243444 hasPublicationYear "2013" @default.
• W2327243444 type Work @default.
• W2327243444 sameAs 2327243444 @default.
• W2327243444 citedByCount "0" @default.
• W2327243444 crossrefType "journal-article" @default.
• W2327243444 hasAuthorship W2327243444A5049712147 @default.
• W2327243444 hasAuthorship W2327243444A5059392164 @default.
• W2327243444 hasAuthorship W2327243444A5059439989 @default.
• W2327243444 hasAuthorship W2327243444A5079087568 @default.
• W2327243444 hasConcept C120665830 @default.
• W2327243444 hasConcept C121332964 @default.
• W2327243444 hasConcept C126322002 @default.
• W2327243444 hasConcept C141071460 @default.
• W2327243444 hasConcept C168563851 @default.
• W2327243444 hasConcept C23131810 @default.
• W2327243444 hasConcept C2776478404 @default.
• W2327243444 hasConcept C2780400711 @default.
• W2327243444 hasConcept C44249647 @default.
• W2327243444 hasConcept C500558357 @default.
• W2327243444 hasConcept C61511704 @default.
• W2327243444 hasConcept C71924100 @default.
• W2327243444 hasConcept C95190672 @default.
• W2327243444 hasConceptScore W2327243444C120665830 @default.
• W2327243444 hasConceptScore W2327243444C121332964 @default.
• W2327243444 hasConceptScore W2327243444C126322002 @default.
• W2327243444 hasConceptScore W2327243444C141071460 @default.
• W2327243444 hasConceptScore W2327243444C168563851 @default.
• W2327243444 hasConceptScore W2327243444C23131810 @default.
• W2327243444 hasConceptScore W2327243444C2776478404 @default.
• W2327243444 hasConceptScore W2327243444C2780400711 @default.
• W2327243444 hasConceptScore W2327243444C44249647 @default.
• W2327243444 hasConceptScore W2327243444C500558357 @default.
• W2327243444 hasConceptScore W2327243444C61511704 @default.
• W2327243444 hasConceptScore W2327243444C71924100 @default.
• W2327243444 hasConceptScore W2327243444C95190672 @default.
• W2327243444 hasIssue "Suppl 1" @default.
• W2327243444 hasLocation W23272434441 @default.
• W2327243444 hasOpenAccess W2327243444 @default.
• W2327243444 hasPrimaryLocation W23272434441 @default.
• W2327243444 hasRelatedWork W2062898667 @default.
• W2327243444 hasRelatedWork W2092357608 @default.
• W2327243444 hasRelatedWork W2094000083 @default.
• W2327243444 hasRelatedWork W2375232986 @default.
• W2327243444 hasRelatedWork W2748167152 @default.
• W2327243444 hasRelatedWork W2918435398 @default.
• W2327243444 hasRelatedWork W3036326648 @default.
• W2327243444 hasRelatedWork W3049293497 @default.
• W2327243444 hasRelatedWork W4220680894 @default.
• W2327243444 hasRelatedWork W4323040206 @default.
• W2327243444 hasVolume "99" @default.
• W2327243444 isParatext "false" @default.
• W2327243444 isRetracted "false" @default.
• W2327243444 magId "2327243444" @default.
• W2327243444 workType "article" @default.